On the effect on human thrombocytes of synthetic organic fibrinolytic compounds.
D000227:Adenine Nucleotides / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D002462:Cell Membrane; D002746:Chlorpromazine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D005453:Fluorescence; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D009705:Nucleosides / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D012709:Serum Albumin / Q000494:pharmacology; D013386:Succinates / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000227:Adenine Nucleotides; D001565:Benzoates; D005343:Fibrinolytic Agents; D006146:Guanidines; D009705:Nucleosides; D012459:Salicylates; D012709:Serum Albumin; D013386:Succinates; D062367:ortho-Aminobenzoates; D010042:Ouabain; D005439:Flufenamic Acid; D011239:Prednisolone; D013917:Thrombin; D002746:Chlorpromazine; D004837:Epinephrine